First Light Acquisition Group, Inc.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | Sep 10, 2021 |
| CEO | Thomas A. Vecchiolla |
| Left Lead | Guggenheim Securities |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12 + 3 + 3 + 3 + 3 |
| IPO Sector | Technology ▶ |
| IPO Geography | Global |
| Target Company | Calidi Biotherapeutics |
| Deal Announced | Jan 9, 2023 |
| Deal Size, $M | $335.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Aug 28, 2023 |
| Amendment Vote | Sep 13, 2022 |
| Closing Date | Sep 12, 2023 |
Formerly FLAG
CLDI
CLDI/W
| Price | $1.55 $0.01 |
|---|---|
| Last closing price | $1.54 |
| H/L, today | $1.53 / $1.59 |
| H/L, 52-week | $1.50 / $5.00 |
| Volume, today | 62,997 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.